SLC2A1 and Dyskinesia: In a previous study, researchers from several hospitals in China have retrospectively collected clinical data from 19 children with GLUT1-DS; all patients were treated with the KD, which was effective in 18 cases in terms of seizure control, 11 cases had dyskinesia improvement and 18 cases had cognitive function improvement (40).